Edgewise Therapeutics, Inc. (EWTX)
Develops drugs to treat genetic muscle and heart disorders.
$40.35-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+182.0%
The outlook
EWTX is trading near recent highs within its 52-week range, with the price sitting above both its 50- and 200-day moving averages. Analyst consensus leans strongly bullish, with an average price target about 24% above the current level. The stock's technical positioning and analyst sentiment both reflect an optimistic near-term view.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 13 analysts
Price trendAbove its 50- & 200-day averages
52-week range78% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Analyst price target
~12-month · 13 analysts$49.92average target+23.7% vs now
Now $40.35
Low $30.00High $66.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.34B
52-wk high
$48.40
52-wk low
$12.30
50-day avg
$37.67
200-day avg
$29.22
Trailing P/E
—